| Views | |
|---|---|
| Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 326 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 10 | 13 | 11 | 27 | 10 | 11 | 6 |
| Views | |
|---|---|
| 2021_Correll_etal.pdf | 7627 |
